Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gastritis II: Pathophysiology

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

Peptic Ulcer

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study.

The lancet. Gastroenterology & hepatology·2018

Same author

Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models.

Scientific reports·2018

Same author

CagL from Helicobacter pylori has ADP-ribosylation activity and exerts partial protective efficacy in mice.

Archives of biochemistry and biophysics·2017

Same author

Prevalence of M75 <i>Streptococcus pyogenes</i> Strains Harboring <i>slaA</i> Gene in Patients Affected by Pediatric Obstructive Sleep Apnea Syndrome in Central Italy.

Frontiers in microbiology·2017

Same author

Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccination.

Scientific reports·2016

Same author

Paediatric obstructive sleep apnoea syndrome (OSAS) is associated with tonsil colonisation by Streptococcus pyogenes.

Scientific reports·2016

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

Helicobacter pylori and inflammation.

Paolo Ruggiero¹

¹Novartis Vaccines and Diagnostics S.R.L, Research Center, Via Fiorentina 1, 53100 Siena, Italy. paolo.ruggiero@novartis.com

Current Pharmaceutical Design

|December 28, 2010

Summary

Helicobacter pylori infection causes inflammation, potentially leading to ulcers or cancer. Host and bacterial factors interact, determining disease severity and the need for further research into protective immunity.

Area of Science:

Microbiology
Immunology
Gastroenterology

Background:

Helicobacter pylori infects over 50% of the global population, colonizing the gastric mucosa.
While often asymptomatic, H. pylori infection can progress to chronic gastritis, peptic ulcers, MALT lymphoma, and gastric cancer.
The bacterium's colonization involves penetrating mucus, adhering to epithelium, acquiring nutrients, and evading host immunity.

Purpose of the Study:

To explore the complex interplay between H. pylori virulence factors and host responses in disease pathogenesis.
To understand the mechanisms driving gastric inflammation and its progression to severe pathologies.
To identify knowledge gaps in host-pathogen interactions and protective immunity against H. pylori.

Main Methods:

Review of clinical and experimental observations on H. pylori infection.

More Related Videos

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

Related Experiment Videos

Last Updated: Jun 5, 2026

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Mouse Models Of Helicobacter Infection And Gastric Pathologies

Published on: October 18, 2018

Analysis of bacterial colonization stages and virulence factors.

Investigation of host factors influencing chronic inflammation and pathological outcomes.

Main Results:

Both bacterial virulence factors and host immune responses contribute significantly to H. pylori pathogenesis.
Specific combinations of host and pathogen genotypes are associated with severe disease development.
Host-pathogen co-adaptation often results in harmless colonization, but severe outcomes can occur.

Conclusions:

Understanding H. pylori pathogenesis requires detailed knowledge of host-pathogen interactions.
Further research is crucial for developing effective strategies against H. pylori infection and associated diseases.
Targeting mechanisms of host-pathogen interaction and protective immunity is essential for combating H. pylori.